服贸会医卫服务专题前瞻：现场可体验AI诊疗，还有减重讲座

Core Viewpoint - The 2025 China International Service Trade Fair (CIFTIS) will take place from September 10 to 14 in Beijing, focusing on health and wellness services, with a theme of "Intelligent Future, Healthy Life" highlighting AI applications in healthcare [1][4]. Group 1: Event Overview - The health and wellness services section will feature nearly 20 meetings, forums, and related activities, including the "Capital International Medical Conference" [1][4]. - The health services section has achieved a 54% participation rate from Fortune 500 and industry-leading companies, with an internationalization rate of 53% [4]. Group 2: AI and Healthcare Innovations - The "Intelligent Medical Cloud Matrix" will showcase 15 stages of AI applications in precise diagnosis and biomedicine research, emphasizing capabilities like data labeling and intelligent monitoring [4]. - Attendees will experience AI diagnostic tools, such as an AI camera for retinal scans that can diagnose conditions like hypertension and diabetes [4]. Group 3: Traditional Chinese Medicine (TCM) Innovations - TCM will present its latest intelligent diagnostic applications, including the "AI TCM Future Clinic" and robots for precise acupuncture [5]. - The "24 Solar Terms Health Check-in Activity" will be introduced, integrating traditional medicine culture with interactive experiences [7]. Group 4: Health Management and Elderly Care - The event will include lectures on health management topics such as weight management and psychological health, focusing on integrated medical and elderly care solutions [6][7]. - The exhibition will highlight the latest trends in elderly health and care services, including smart home solutions [7]. Group 5: Supporting Activities and Innovations - The fair will host the "2025 CIFTIS Health and Wellness Services Innovation Achievement Release" and the "Seventh Technology Innovation Competition" focusing on robotic medical applications [8]. - Notable innovations include Siemens' photon-counting CT, GE Healthcare's MRI with integrated treatment solutions, and AstraZeneca's $2.5 billion investment in a new R&D center in Beijing [8].